NOVO-B.CO Novo Nordisk B A/S
Performance
0% Past Week
Market Cap
2.33T
Day’s Range
52W Range
Volume (3M)
1.5M
Price-Earnings Ratio
42.22
Revenue
176.95B
Novo Nordisk B A/S Latest News

About Novo Nordisk B A/S
Novo Nordisk B A/S is a healthcare company that researches, develops, manufactures, and markets pharmaceutical products. Operating internationally, the company was founded in 1989 and has its headquarters in Bagsvaerd, Denmark. Novo Nordisk stock is available on the CSE under the ticker NOVO-B.CO. Add this instrument to your eToro watchlist to monitor NOVO-B.CO share price movements.
Show More54.3K
Employees
DK
HQ
1931
Founded
Lars Fruergaard Jørgensen, MBA
CEO
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
60
High
Industry
Avg. 47
73
Environment
67
Social
50
Governance
People Also Bought
- LLY Eli Lilly & Co 0.50%
- DANSKE.CO Danske Bank A/S -5.50%
- DSV.CO DSV A/S -2.99%
- MAERSKB.CO A P Moller Maersk -3.22%
- NVO Novo-Nordisk A/S SPONS ADR 1.97%
1035.44